Manufacturing Whitepaper: CDMOs at a Crossroads BioSpaceIn this whitepaper, BioSpace reviews the major trends impacting the CDMO sector and the evolving relationship between sponsors and providers.ManufacturingRead full story pharminent April 15, 2026 BioSpace In this whitepaper, BioSpace reviews the major trends impacting the CDMO sector and the evolving relationship between sponsors and providers. ManufacturingRead full story Post navigation Previous: Scientists issue call to arms over antifungal resistanceNext: BMS makes a Beeline, bringing 5 assets to biotech’s $300M precision immunology debut Related Stories Manufacturing Eli Lilly pledges $4.5bn to bolster Indiana-based manufacturing pharminent May 7, 2026 Manufacturing Lilly inflates US facility investment spending by $4.5bn pharminent May 6, 2026 Manufacturing PCI adds US sterile fill/finish capabilities through $1B global expansion drive pharminent May 4, 2026
